Quantcast
ZME Science
  • CoronavirusNEW
  • News
  • Environment
    • Climate
    • Animals
    • Renewable Energy
    • Eco tips
    • Environmental Issues
    • Green Living
  • Health
    • Alternative Medicine
    • Anatomy
    • Diseases
    • Genetics
    • Mind & Brain
    • Nutrition
  • Future
  • Space
  • Feature
    • Feature Post
    • Art
    • Great Pics
    • Design
    • Fossil Friday
    • AstroPicture
    • GeoPicture
    • Did you know?
    • Offbeat
  • More
    • About
    • The Team
    • Advertise
    • Contribute
    • Our stance on climate change
    • Privacy Policy
    • Contact
No Result
View All Result
ZME Science

No Result
View All Result
ZME Science
No Result
View All Result
Home Science

Researchers hone in on potential antibodies against OCD, maybe other mental disorders too

We're still years away from a useable treatment, but we are pursuing it.

Alexandru Micu by Alexandru Micu
April 22, 2020
in Science

Researchers at the Queen Mary University of London and the University of Roehampton, London report finding a potential antibody treatment against obsessive compulsive disorder (OCD) — in mice.

Image via Pixabay.

The team reports that human patients suffering from OCD show increased levels of a protein called Immuno-moodulin (Imood) in lymphocytes, a type of immune cell. Mice whose lymphocytes were modified to show the same high levels of Imood showed behaviors that are characteristic of anxiety and stress, such as digging and excessive grooming, which are related to OCD.

However, the team also showed that an antibody can be used to neutralize the protein, which reduced the animals’ apparent anxiety levels in lab tests. The findings might help us develop a similar treatment for humans.

There’s a pill for that

“There is mounting evidence that the immune system plays an important role in mental disorders,” said Professor Fulvio D’Acquisto, a professor of immunology at the University of Roehampton and honorary professor of Immunopharmacology at Queen Mary University of London, who led the research. “And in fact people with auto-immune diseases are known to have higher than average rates of mental health disorders such as anxiety, depression and OCD.”

“Our findings overturn a lot of the conventional thinking about mental health disorders being solely caused by the central nervous system.”

Professor D’Acquisto first identified Imood by chance while studying a different protein (Annexin-A1) and the role it plays in autoimmune diseases such as multiple sclerosis and lupus. As part of the study, he engineered lab mice to overexpress this protein in their immune cells in the hopes of inducing autoimmune diseases in the animals and found that the mice were more anxious than normal. Upon closer inspection, the team found that one protein was especially active and likely protected the animals from such diseases.

Curious about its effects, the team administered an antibody treatment to the mice that would block the Imood gene — and their behavior returned to normal within a couple of days. This led the team to christen the gene encoding it “Immuno-moodulin”.

Get more science news like this...

Join the ZME newsletter for amazing science news, features, and exclusive scoops. More than 40,000 subscribers can't be wrong.

   

Later on, the team tested the immune cells of 23 patients with OCD and 20 healthy volunteers to check if they showed any differences in Imood levels. OCD patients had around six times higher expression of these genes than the controls. Together with previous findings, the team is confident that this showcases the role this protein has in mental health disorders such as OCD or ADHD (Attention-Deficit/Hyperactivity Disorder).

The team believes that the gene encoding the protein doesn’t directly influence brain functions, but that its activity is tied to that of other genes in brain cells that are linked to disorders like OCD.

“This is work we still have to do to understand the role of Imood,” says Professor D’Acquisto. “We also want to do more work with larger samples of patients to see if we can replicate what we saw in the small number we looked at in our study.”

“It is early still, but the discovery of antibodies — instead of the classical chemical drugs — for the treatment of mental disorders could radically change the life of these patients as we foresee a reduced chance of side effects,” he adds.

The team is collaborating with the biopharmaceutical company UCB to develop antibodies against Imood that can be used in humans and to understand how this could be used to treat patients with mental disorders. Professor D’Acquisto estimates it could take up to five years before a treatment is ready for clinical trials.

The paper “Immuno-moodulin: A new anxiogenic factor produced by Annexin-A1 transgenic autoimmune-prone T cells” has been published in the journal Brain, Behavior, and Immunity.

Tags: adhdbraindisordersmental healthOCD
Alexandru Micu

Alexandru Micu

Stunningly charming pun connoisseur, I have been fascinated by the world around me since I first laid eyes on it. Always curious, I'm just having a little fun with some very serious science.

Follow ZME on social media

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
  • Coronavirus
  • News
  • Environment
  • Health
  • Future
  • Space
  • Feature
  • More

© 2007-2019 ZME Science - Not exactly rocket science. All Rights Reserved.

No Result
View All Result
  • Coronavirus
  • News
  • Environment
    • Climate
    • Animals
    • Renewable Energy
    • Eco tips
    • Environmental Issues
    • Green Living
  • Health
    • Alternative Medicine
    • Anatomy
    • Diseases
    • Genetics
    • Mind & Brain
    • Nutrition
  • Future
  • Space
  • Feature
    • Feature Post
    • Art
    • Great Pics
    • Design
    • Fossil Friday
    • AstroPicture
    • GeoPicture
    • Did you know?
    • Offbeat
  • More
    • About
    • The Team
    • Advertise
    • Contribute
    • Our stance on climate change
    • Privacy Policy
    • Contact

© 2007-2019 ZME Science - Not exactly rocket science. All Rights Reserved.